Urinary tract infection in women

Advanced Studies in Medicine

Volumn 6, Issue 1, 2006, Pages 24-29

  French, Linda ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFALEXIN; CEFTRIAXONE; COTRIMOXAZOLE; ESTROGEN; FOSFOMYCIN; GENTAMICIN; NITROFURANTOIN; OFLOXACIN; PHENAZOPYRIDINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TRIMETHOPRIM;

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; CRANBERRY JUICE; CYSTITIS; DIABETES MELLITUS; DIAGNOSTIC TEST; DRUG COST; ECONOMIC ASPECT; HIGH RISK PATIENT; HUMAN; IMMUNE DEFICIENCY; POSTMENOPAUSE; PRACTICE GUIDELINE; PROPHYLAXIS; PYELONEPHRITIS; QUALITY OF LIFE; RECURRENT DISEASE; REVIEW; RISK FACTOR; URINALYSIS; URINARY TRACT INFECTION; URINARY TRACT MALFORMATION; URINE CULTURE;

EID: 32344443881     PISSN: 15303004     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (60)

1. Schappert SM. Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 1997. Vital Health Stat 13. 1999:i-iv, 1-39.
2. Foxman B, Barlow R, D'Arcy H, Gillespie B, Sobel JD. Urinary tract infection: self-reported incidence and associated costs. Ann Epidemiol. 2000;10:509-515.
3. Molander U, Arvidsson L, Milsom I, Sandberg T. A longitudinal cohort study of elderly women with urinary tract infections. Maturitas. 2000;34:127-131.
4. Ronald A. The etiology of urinary tract infection: traditional and emerging pathogens. Am J Med. 2002;113(suppl 1A):14S-19S.
5. Gupta K, Scholes D, Stamm WE. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA. 1999;281:736-738.
6. Foxman B, Gillespie B, Koopman J, et al. Risk factors for second urinary tract infection among college women. Am J Epidemiol. 2000;151:1194-1205.
7. Hooton TM, Scholes D, Hughes JP, et al. A prospective study of risk factors for symptomatic urinary tract infection in young women. N Engl J Med. 1996;335:468-474.
8. Scholes D, Hooton TM, Roberts PL, Stapleton AE, Gupta K, Stamm WE. Risk factors for recurrent urinary tract infection in young women. J Infect Dis. 2000;182:1177-1182.
9. Nicole LE, Hording GK, Preiksaitis J, Ronald AR. The association of urinary tract infection with sexual intercourse. J Infect Dis. 1982;146:579-583.
10. Leibovici L, AlpertG, Laor A, Kalter-Leibovici O, Danon YL. Urinary tract infections ond sexual activity in young women. Arch Intern Med. 1987;147:345-347.
11. Hooton TM, Hillier S, Johnson C, Roberts PL, Stamm WE. Escherichia coli bacteriuria and contraceptive method. JAMA. 1991;265:64-69.
12. Hooton TM, Fennell CL, Clark AM, Stamm WE. Nonoxynol-9: differential antibacterial activity and enhancement of bacterial adherence to vaginal epithelial cells. J Infect Dis. 1991;164:1216-1219.
13. Bent S, Nallamothu BK, Simel DL, Fihn SD, Saint S. Does this woman have an acute uncomplicated urinary tract infection? JAMA. 2002;287:2701-2710.
14. Hurlbut TA 3rd, Littenberg B. The diagnostic accuracy of rapid dipstick tests to predict urinary tract infection. Am J Clin Pathol. 1991;96:582-588.
15. Sultana RV, Zaistein S, Cameron P, Campbell D. Dipstick urinalysis and the accuracy of the clinical diagnosis of urinary tract infection. J Emerg Med. 2001;20:13-19.
16. Bulloch B, Bausher JC, Pomerantz WJ, Connors JM, Mahabee-Gittens M, Dowd MD. Can urine clority exclude the diagnosis of urinary tract infection? Pediatrics. 2000;106:E60.
17. Lifshitz E, Kromer L. Outpatient urine culture: does collection technique matter? Arch Intern Med. 2000;160:2537-2540.
18. Kunin CM, White LV, Hua TH. A reassessment of the importance of "low-count" bacteriuria in young women with acute urinary symptoms. Ann Intern Med. 1993;119:454-460.
19. Papanicolaou N, Pfister RC. Acute renal infections. Radiol Clin North Am. 1996;34:965-995.
20. Johnson JR, Vincent LM, Wang K, Roberts PL, Stamm WE. Renal ultrasonographic correlates of acute pyelonephritis. Clin Infect Dis. 1992;14:15-22.
21. Fihn SD, Johnson C, Roberts PL, Running K, Stamm WE. Trimethoprim- sulfamethoxazole for acute dysuria in women: a single-dose or 10-day course. A double-blind, randomized trial. Ann Intern Med. 1988;108:350-357.
22. McCarty JM, Richard G, Huck W, et al. A randomized trial of short-course ciprofloxadn, ofloxacin, or trimefhoprim/sulfamethoxazole for the treatment of acute urinory tract infection in women. Ciprofloxacin Urinary Tract Infection Group. Am J Med. 1999;106:292-299.
23. Warren JW, Abrutyn E, Hebel JR, Johnson JR, Schaeffer AJ, Stamm WE. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis. 1999;29:745-758.
24. Car J, Svab I, Kersnik J, Vegnuti M. Management of lower urinary tract infection in women by Slovene GPs. Fam Pract. 2003;20:452-456.
25. Gupta K, Hooton TM, Stamm WE. Increasing antimicrobial resistance and the management of uncomplicated community-ocquired urinary tract infections. Ann Intern Med. 2001;135:41-50.
26. Manges AR, Johnson JR, Foxman B, O'Bryan TT, Fullerton KE, Riley LW. Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group. N Engl J Med. 2001;345:1007-1013.
27. Wright SW, Wrenn KD, Haynes ML. Trimethoprim-sulfamethoxazole resistance among urinary coliform isolates. J Gen Intern Med. 1999;14:606-609.
28. Baerheim A, Digranes A, Hunskaar S. Are resistance patterns in uropathogens published by microbiological laboratories valid for general practice? APMIS. 1999;107:676-680.
29. Hooton TM, Stamm WE. Diagnosis and treatment of uncomplicated urinary tract infection, Infect Dis Clin North Am. 1997;11:551-581.
30. Vinson DR, Quesenberry CP Jr. The safety of telephone management of presumed cystitis in women. Arch Intern Med. 2004;164:1026-1029.
31. Minassian MA, Lewis DA, Chattopadhyay D, Bovill B, Duckworth GJ, Williams JD. A comparison between single-dose fosfomycin trometamol (Monuril) and a 5-day course of trimethoprim in the treatment of uncomplicated lower urinary tract infection in women, Int J Antimicrob Agents. 1998;10:39-47.
32. Stein GE. Comparison of single-dose fosfomycin and a 7-day course of nitrofurantoin in female patients with uncomplicated urinary tract infection. Clin Ther. 1999;21:1864-1872.
33. Pinson AG, Philbrick JT, Lindbeck GH, Schorling JB. ED management of acute pyelonephritis in women: a cohort study. Am J Emerg Med. 1994;12:271-278.
34. Sheinfeld J, Schaeffer AJ, Cardon-Cardo C, Ragatko A, Fair WR. Association of the Lewis blood-group phenotype with recurrent urinary tract infections in women. N Engl J Med. 1989;320:773-777.
35. Stapleton A. Urinary tract infections in patients with diabetes. Am J Med. 2002;113(suppl 1A):805-845.
36. Stamm WE, McKevitt M, Roberts PL, White NJ. Natural history of recurrent urinary tract infections in women. Rev Infect Dis. 1991;13:77-84.
37. Wong ES, McKevitt M, Running K, Counts GW, Turck M, Stamm WE. Management of recurrent urinary tract infections with patient-administered single-dose therapy. Ann Intern Med. 1985;102:302-307.
38. Gupta K, Hooton TM, Roberts PL, Stamm WE. Patient-initiated treatment of uncomplicated recurrent urinary tract infections in young women. Ann Intern Med. 2001;135:9-16.
39. Stapleton A, Latham RH, Johnson C, Stamm WE. Postcoital antimicrobial prophylaxis for recurrent urinary tract infection. A randomized, double-blind, placebo-controlled trial. JAMA. 1990;264:703-706.
40. Lowe FC, Fagelman E. Cranberry juice and urinary tract infections: what is the evidence? Urology. 2001;57:407-413.
41. Kontiokari T, Sundqvist K, Nuutinen M, Pokka T, Koskela M, Uhari M. Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ. 2001;322:1571.
42. Strom BL, Collins M, West SL, Kreisberg J, Weller S. Sexual activity, contraceptive use, and other risk factors for symptomatic and asymptomatic bacteriuria. A case-control study. Ann Intern Med. 1987;107:816-823.
43. Rosenberg M. Pharmacoeconomics of treating uncomplicated urinary tract infections. Int J Antimicrob Agents. 1999;11:247-251.
44. Barry HC, Hickner J, Ebell MH, Ettenhofer T. A randomized controlled trial of telephone management of suspected urinary tract infections in women. J Fam Pracf. 2001;50:589-594.
45. Fenwick EA, Briggs AH, Hawke CI. Management of urinary tract infection in general practice: a cost-effectiveness analysis. Br J Gen Pract. 2000;50:635-639.
46. Huang X, Hartzema AG, Raasch RH, Kauf TL, Norwood GJ. Economic assessment of three antimicrobial therapies for uncomplicated urinary tract infection in women. Clin Ther. 1999;21:1578-1588.
47. Eriksen B. A randomized, open, parallel-group study on the preventive effect of an estradiol-releasing vaginal ring (Estring) on recurrent urinary tract infections in postmenopausal women. Am J Obstet Gynecol. 1999;180:1072-1079.
48. Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med. 1993;329:753-756.
49. Powers JS, Billings FT, Behrendt D, Burger MC. Antecedent factors in urinary tract infections among nursing home patients. South Med J. 1988;81:734-735.
50. Raz R, Gennesin Y, Wasser J, et al. Recurrent urinary tract infections in postmenopausal women. Clin Infect Dis. 2000;30:152-156.
51. Barkham TM, Martin FC, Eykyn SJ. Delay in the diagnosis of bacteraemic urinary tract infection in elderly patients. Age Ageing. 1996;25:130-132.
52. Abrutyn E, Mossey J, Levison M, Boscia J, Pitsakis P, Kaye D. Epidemiology of asymptomatic bacteriuria in elderly women. J Am Geriatr Soc. 1991;39:388-393.
53. Monane M, Gurwitz JH, Lipsitz LA, Glynn RJ, Choodnovskiy I, Avorn J. Epidemiologic and diagnostic aspects of bacteriuria: a longitudinal study in older women. J Am Geriatr Soc. 1995;43:618-622.
54. Vogel T, Verreault R, Gourdeau M, Morin M, Grenier-Gosselin L, Rochette L. Optimal duration of antibiotic therapy for uncomplicated urinary tract infection in older women: a double-blind randomized controlled trial. CMAJ. 2004;170:469-473.
55. Pastore LM, Savitz DA, Thorp JM Jr, Koch GG, Hertz-Picciotto I, Irwin DE. Predictors of symptomatic urinary tract infection after 20 weeks' gestation. J Perinatol, 1999;19:488-493.
56. MacDonald TM. The economic evaluation of antibiotic therapy: relevance to urinary tract infection. J Antimicrob Chemother. 1994;33(suppl A):137-145.
57. Schieve LA, Handler A, Hershow R, Persky V, Davis F. Urinary tract infection during pregnancy: its association with maternal morbidity and perinatal outcome. Am J Public Health. 1994;84:405-410.
58. Gratacos E, Torres PJ, Vila J, Alonso PL, Cararach V. Screening and treatment of asymptomatic bacteriuria In pregnancy prevent pyelonephritis. J Infect Dis. 1994;169:1390-1392.
59. Ronald A, Ludwig E. Urinary tract infections in adults with diabetes. Int J Antimicrob Agents. 2001;17(4):287-292.
60. Metz LM, McGuinness SD, Harris C. Urinary tract infections may trigger relapse in multiple sclerosis. Axone. 1998;19:67-70.